Cargando…

Secondary Stroke Prevention in Polish Adults: Results from the LIPIDOGRAM2015 Study

Background: The purpose of the study was to evaluate secondary stroke prevention in Poland and its association with sociodemographic factors, place of residence, and concomitant cardiovascular risk factors. Material and methods: From all patients in LIPIDOGRAM2015 Study (n = 13,724), 268 subjects ha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Labuz-Roszak, Beata, Banach, Maciej, Skrzypek, Michal, Windak, Adam, Tomasik, Tomasz, Mastej, Miroslaw, Tomaszewski, Maciej, Mikhailidis, Dimitri P., Toth, Peter P., Catapano, Alberico, Ray, Kausik K., Howard, George, Lip, Gregory Y. H., Charchar, Fadi J., Sattar, Naveed, Williams, Bryan, MacDonald, Thomas M., Penson, Peter, Jozwiak, Jacek J.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8509736/ https://www.ncbi.nlm.nih.gov/pubmed/34640490 http://dx.doi.org/10.3390/jcm10194472

Ejemplares similares

Serum antinuclear autoantibodies are associated with measures of oxidative stress and lifestyle factors: analysis of LIPIDOGRAM2015 and LIPIDOGEN2015 studies
por: Krzemień, Paweł, et al.
Publicado: (2021)

The Differences in the Prevalence of Cardiovascular Disease, Its Risk Factors, and Achievement of Therapeutic Goals among Urban and Rural Primary Care Patients in Poland: Results from the LIPIDOGRAM 2015 Study
por: Studziński, Krzysztof, et al.
Publicado: (2021)

Association of body mass index and long-term mortality in patients from nationwide LIPIDOGRAM 2004–2015 cohort studies: no obesity paradox?
por: Osadnik, Tadeusz, et al.
Publicado: (2023)

Design and rationale of a nationwide screening analysis from the LIPIDOGRAM2015 and LIPIDOGEN2015 studies
por: Jóźwiak, Jacek J., et al.
Publicado: (2020)

Analysis of the impact of sex and age on the variation in the prevalence of antinuclear autoantibodies in Polish population: a nationwide observational, cross-sectional study
por: Krzemień, Paweł, et al.
Publicado: (2021)

Relationship Between Anti-DFS70 Autoantibodies and Oxidative Stress
por: Krzemień, Paweł, et al.
Publicado: (2022)

The Relation of Rapid Changes in Obesity Measures to Lipid Profile - Insights from a Nationwide Metabolic Health Survey in 444 Polish Cities
por: Kaess, Bernhard M., et al.
Publicado: (2014)

May Measurement Month 2019: an analysis of blood pressure screening results from Poland
por: Sęk-Mastej, Anna, et al.
Publicado: (2021)

Do we know more about hypertension in Poland after the May Measurement Month 2017?—Europe
por: Małyszko, Jolanta, et al.
Publicado: (2019)

The association between coffee and caffeine consumption and renal function: insight from individual-level data, Mendelian randomization, and meta-analysis
por: Mazidi, Mohsen, et al.
Publicado: (2021)

May Measurement Month 2018: an analysis of blood pressure screening campaign results from Poland
por: Jankowski, Piotr, et al.
Publicado: (2020)

Dietary food patterns and glucose/insulin homeostasis: a cross-sectional study involving 24,182 adult Americans
por: Mazidi, Mohsen, et al.
Publicado: (2017)

Efficacy of Statin Therapy in Pulmonary Arterial Hypertension: A Systematic Review and Meta-Analysis
por: Rysz-Górzynska, Magdalena, et al.
Publicado: (2016)

The Role of Nutraceuticals in the Optimization of Lipid-Lowering Therapy in High-Risk Patients with Dyslipidaemia
por: Penson, Peter E., et al.
Publicado: (2020)

Drucebo effect – the challenge we should all definitely face!
por: Banach, Maciej, et al.
Publicado: (2021)

Nutraceuticals for the Control of Dyslipidaemias in Clinical Practice
por: Penson, Peter E., et al.
Publicado: (2021)

Colchicine and Cardiovascular Outcomes: a Critical Appraisal of Recent Studies
por: Banach, Maciej, et al.
Publicado: (2021)

Adherence to statin therapy: it seems we know everything, yet we do nothing
por: Banach, Maciej, et al.
Publicado: (2022)

Association between telomere length and complete blood count in US adults
por: Mazidi, Mohsen, et al.
Publicado: (2017)

PoLA/CFPiP/PCS Guidelines for the Management of Dyslipidaemias for Family Physicians 2016
por: Banach, Maciej, et al.
Publicado: (2016)

Effect of using cardiovascular risk scoring in routine risk assessment in primary prevention of cardiovascular disease: an overview of systematic reviews
por: Studziński, Krzysztof, et al.
Publicado: (2019)

LDL-C: lower is better for longer—even at low risk
por: Penson, Peter E., et al.
Publicado: (2020)

Introducing the ‘Drucebo’ effect in statin therapy: a systematic review of studies comparing reported rates of statin‐associated muscle symptoms, under blinded and open‐label conditions
por: Penson, Peter E., et al.
Publicado: (2018)

Antiplatelet and anticoagulant therapy in elderly people with type 2 diabetes mellitus in Poland (based on the PolSenior Study)
por: Łabuz-Roszak, Beata, et al.
Publicado: (2017)

Oral anticoagulant and antiplatelet drugs used in prevention of cardiovascular events in elderly people in Poland
por: Labuz-Roszak, Beata, et al.
Publicado: (2012)

Searching for factors associated with resistance to acetylsalicylic acid used for secondary prevention of stroke
por: Łabuz-Roszak, Beata, et al.
Publicado: (2015)

CETP inhibition in the REVEAL trial: could we aim higher?
por: Sahebkar, Amirhossein, et al.
Publicado: (2020)

More Good News on Statins and COVID-19
por: Katsiki, Niki, et al.
Publicado: (2021)

Is type 2 diabetes mellitus a coronary heart disease equivalent or not? Do not just enjoy the debate and forget the patient!
por: Katsiki, Niki, et al.
Publicado: (2019)

Lipid-lowering therapy and renin-angiotensin-aldosterone system inhibitors in the era of the COVID-19 pandemic
por: Katsiki, Niki, et al.
Publicado: (2020)

RNA Silencing in the Management of Dyslipidemias
por: Henney, Neil C., et al.
Publicado: (2021)

Relationship between low-density lipoprotein cholesterol, lipid-lowering agents and risk of stroke: a meta-analysis of observational studies (n = 355,591) and randomized controlled trials (n = 165,988)
por: Banach, Maciej, et al.
Publicado: (2022)

Association of Bempedoic Acid Administration With Atherogenic Lipid Levels in Phase 3 Randomized Clinical Trials of Patients With Hypercholesterolemia
por: Banach, Maciej, et al.
Publicado: (2020)

2020 Guidelines of the Polish Society of Laboratory Diagnostics (PSLD) and the Polish Lipid Association (PoLA) on laboratory diagnostics of lipid metabolism disorders
por: Solnica, Bogdan, et al.
Publicado: (2020)

Dysfunctional high-density lipoprotein: not only quantity but first of all quality?
por: Agouridis, Aris P., et al.
Publicado: (2015)

Statins as anti-pyroptotic agents
por: Khalifeh, Masoomeh, et al.
Publicado: (2021)

A Novel Y-Specific Long Non-Coding RNA Associated with Cellular Lipid Accumulation in HepG2 cells and Atherosclerosis-related Genes
por: Molina, Elsa, et al.
Publicado: (2017)

Lipid-lowering therapies and achievement of LDL-cholesterol targets
por: Rizzo, Manfredi, et al.
Publicado: (2012)

Erythropoietin update 2011
por: Kowalczyk, Mariusz, et al.
Publicado: (2011)

Could Lowering Phytosterol Absorption as Part of Lipid-Lowering Therapy Have a Beneficial Effect on Residual Risk?
por: Anagnostis, Panagiotis, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_1s8qg09ds6mlg447ea06f81gjh